Close

H.C. Wainwright Downgrades GW Pharma (GWPH) to Buy

February 4, 2021 6:55 AM EST Send to a Friend
H.C. Wainwright analyst Douglas Tsao downgraded GW Pharma (NASDAQ: GWPH) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login